Home › Funds › Siren, L.L.C. › KYMR

Siren, L.L.C. position in KYMR

Kymera Therapeutics, Inc. · Health Care

Siren, L.L.C. reported holding 2,784,898 shares of KYMR (Kymera Therapeutics, Inc.) in its Q3 2026 13F filing — a position valued at US$311.3M, representing 7.39% of its reported portfolio and ranking #2 among its reported holdings. Siren, L.L.C. has disclosed KYMR holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)2.78M sh
Reported value held$311.32M
Portfolio Weight7.39%
First reportedQ3 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s KYMR position evolved

Siren, L.L.C. first disclosed a stake in KYMR in Q3 2024 at 2,969,733 shares (US$140.6M). The position peaked in Q2 2026 at 2,935,830 shares, worth US$336.7M. Across 9 filings, Siren, L.L.C. increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,784,898 shares valued at US$311.3M — a reduction of -150,932 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.97M $140.56M New
Q4 2024 2.97M $119.47M Hold
Q1 2025 3.24M $88.69M Add
Q2 2025 3.43M $149.60M Add
Q3 2025 3.43M $194.03M Hold
Q4 2025 3.29M $255.75M Reduce
Q1 2026 3.19M $265.43M Reduce
Q2 2026 2.94M $336.65M Reduce
Q3 2026 2.78M $311.32M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (Kymera Therapeutics, Inc.) is a Health Care company. 57 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has Siren, L.L.C. held KYMR?

Siren, L.L.C. has disclosed KYMR holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in KYMR?

As of Q3 2026, Siren, L.L.C. holds 2.78M shares of KYMR (Kymera Therapeutics, Inc.), valued at $311.32M, representing 7.39% of its reported portfolio and ranking #2.

Has Siren, L.L.C. been buying or selling KYMR?

In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in KYMR. The position peaked in Q2 2026 at 2.94M shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.